Vas Narasimhan (Photographer: Simon Dawson/Bloomberg via Getty Images) and Severin Schwan (Roche)

Vas Narasimhan and Sev­erin Schwan each claimed pay pack­ets worth $12M+ for 2021

Two of the top paid Eu­ro­pean phar­ma CEOs have re­port­ed their in­come for 2021. And while both could boast of some hefty pay pack­ages for the year be­hind us, the num­bers are like­ly to be dwarfed as the US ex­ecs — in­clud­ing some lead­ers of much small­er biotechs — be­gin to re­port their com­pen­sa­tion lat­er in the year.

Roche CEO Sev­erin Schwan jumped in­to the lead in this first cut of the in­come num­bers, though not by much. His com­pen­sa­tion pack­age rang up to 11.5 mil­lion CHF ($12.4 mil­lion). And Vas Narasimhan, who took the helm at No­var­tis just 4 years ago, claimed 11.2 mil­lion ($12 mil­lion) CHF.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters